ASC is a leading gene editing & stem cell therapy CRO/CDMO.
Applied StemCell, Inc. (ASC) is a leading gene editing and stem cell therapy CRO/CDMO company. ASC supports gene editing and stem cell therapy development processes with two high-impact platforms: CRISPR/TARGATT™ genome editing and iPSC (GMP grade).
As a CDMO, ASC provides complete GMP gene-editing and cell manufacturing as well as banking services completed in a cGMP CMC facility located in Milpitas, California. The expansion of the cGMP facility will be completed in April 2023.
- GMP Cell Banking
- GMP iPSC Gene Editing
- GMP iPSC/MSC Derived Cell Manufacturing
- Pre-clinical/CRO Services
ASC’s proprietary TARGATT™ technology enables site-specific, stable integration of large DNA fragments into a safe harbor locus more efficiently (~10x better than CRISPR) and faster, with guaranteed transgene expression without the disruption of internal genes and gene silencing. ASC’s TARGATT™ master iPSC line provides an unlimited source of cells of any kind containing therapeutic genes. Application of ASC’s TARGATT™ master iPSC line includes the development of off-the-shelf CAR-iNK/CAR-iT products for immuno cell therapy.
- TARGATT cell libraries
Brands: ASC is a leading gene editing & cell therapy CRO/CDMO with its cGMP facility located in the CA. Learn more about our GMP-grade iPSCs & cell drug manufacturing capabilities for your pipelines.